Table 4. Antibiotic susceptibility characteristics of the EKE bacterial isolates n, (%)*.
| Species | AMC | TPZ | CRO | CTX | CAZ | ATM | FEP | FOX | MEM | SXT | CIP | CN | C | TE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
E. coli (n = 23) |
16 (70) | 14 (61) |
8 (35) |
8 (35) | 4 (17) |
10 (44) |
4 (17) | 12 (52) | 19 (83) | 10 (44) | 5 (22) |
10 (44) | 14 (61) | 9 (39) |
| K. pneumoniae (n = 50) | 30 (60) | 25 (50) | 18 (36) | 13 (26) | 21 (38) | 21 (42) |
18 (36) | 41 (82) | 44 (88) | 13 (26) | 5 (10) |
26 (52) | 19 (38) | 36 (72) |
| Enterobacter (n = 31) | 10 (32) | 18 (58) | 8 (26) |
13 (42) | 10 (32) | 13 (42) |
14 (45) | 2 (7) |
30 (97) | 14 (45) | 20 (65) | 11 (36) | 15 (48) | 20 (65) |
AMC, ampicillin-sulbactam; TPZ, piperacillin-tazobactam; CRO, ceftriaxone; CTX, cefotaxime; CAZ, ceftazidime; ATM, aztreonam; FEP, meropenem; FOX, cefoxitin; MEM, meropenem; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; CN, gentamicin; C, chloramphenicol; TE, tetracycline.
*Refers to percentage of drug susceptible isolates.